Skip to main content
CANF logo

CANF · Can-Fite BioPharma Ltd.

$3.38 +0.07 (+2.11%) At close · Jul 21
Market Cap
$7.24M
Shares
2.14M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
70/100
Short interest 15.0% of shares — P95 Days to cover 1.0 — P15 Price vs VWAP -11.3% — P26 Short-volume trend +24.2% — P97 Short interest change +583.3% — P98 Worst FTD 18.36% of shares — P100

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 321,495 47,052 +274,443 1.00
2026-06-15 47,052 67,832 -20,780 1.48
2026-05-29 67,832 116,564 -48,732 3.06
2026-05-15 116,564 23,418 +93,146 1.00
2026-04-30 23,418 18,629 +4,789 1.00
2026-04-15 18,629 37,433 -18,804 1.00
2026-03-31 37,433 46,458 -9,025 1.00
2026-03-13 46,458 85,759 -39,301 1.00
2026-02-27 85,759 90,169 -4,410 3.84
2026-02-13 90,169 75,562 +14,607 1.15
2026-01-30 75,562 71,744 +3,818 1.10
2026-01-15 71,744 4,068,255 -3,996,511 1.00
2025-12-31 203,413 1,663 +201,749 1.00
2025-12-15 1,663 13,025 -11,362 1.00
2025-11-28 13,025 2,752 +10,273 1.00
2025-11-14 2,752 2,570 +182 1.00
2025-10-31 2,570 2,414 +156 1.00
2025-10-15 2,414 7,327 -4,912 1.00
2025-09-30 7,327 5,123 +2,204 1.02
2025-09-15 5,123 8,950 -3,827 1.00
2025-08-29 8,950 6,371 +2,579 1.16
2025-08-15 6,371 17,926 -11,554 1.00
2025-07-31 17,926 4,680 +13,245 1.00
Showing 1–23 of 23 settlements
Key facts CIK 1536196 CUSIP 13471N409 13F (30d) 1 filings 1 filers Visit website Investor relations